RxDoctor Payments Data

Danielle Donahue, PA

Physician Assistant · Powell, TNNPI 1639817109

Payments from drug & device makers

$1,400in general payments, 2019–2025

Across 70 payments — averaging $20.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$575
  • E.r. Squibb & Sons, L.L.C.$270
  • Medtronic$137
  • Pfizer$133
  • Kiniksa Pharmaceuticals International, PLC$74
  • AstraZeneca$53
  • plus $158 from 8 others

What the payments were for

  • Food & beverage$1,400100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,400 in reported general payments places this provider in the 70th percentile of 2,404 physician assistant providers in Tennessee.

See all physician assistant providers in Tennessee

Medicare billing

Part B allowed, 2024
$40,900
Medicare patients
199
Services billed
837

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban161$148,077
XareltoRivaroxaban22$15,432
Repatha SureclickEvolocumab18$14,555
Bumetanide114$2,187
Metoprolol Succinate130$1,423
Flecainide Acetate39$1,024
Ezetimibe54$885
ClopidogrelClopidogrel Bisulfate84$848
Ranolazine ErRanolazine12$821
Potassium Chloride65$677
Isosorbide Dinitrate28$641
Atorvastatin Calcium81$630
Amlodipine Besylate153$552
Spironolactone117$550
Furosemide196$496

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$133$148,077161 claims
Johnson & JohnsonXarelto$14$15,43222 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 2,404 physician assistant providers in Tennessee.

Other physician assistant in Powell

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →